Genentech’s ‘Born to Breakthrough’ Celebrates 50 Years of Science and Humanity

​West BBDO and Genentech have unveiled 'Born to Breakthrough,' the company’s first-ever brand campaign marking its milestone 50th year. The campaign serves as a compelling example of how a legacy brand can honour its history while boldly redefining its future.

Known as the original biotech company, it was founded 50 years ago on a simple but bold idea: that they could translate science into medicines that change lives. But few people know the depth of Genentech's impact on the world and this campaign provides that opportunity. ‘Born to Breakthrough' is more than a 50th-anniversary celebration; it is a strategic repositioning that translates five decades of scientific leadership into a clear commitment to patient impact for the next 50 years.

In an industry that often leads with clinical data, Genentech is leading with resilience and humanity. The campaign reframes what a breakthrough means by shifting the focus from the lab to people's lives. Instead of leading with scientific achievement, it centres on patients and their ability to overcome disease, stay connected to family, and keep living fully. It shows that Genentech's greatest breakthroughs are not discoveries alone, but the lives made possible because of them.

Bigger than just a commemorative milestone; it is a highly targeted integration that spans TV, digital, OOH, and streaming audio anchored by strategic partnerships designed to bridge the gap between science, innovation, and culture. These include: The New York Times, The Atlantic, KQED, and Pantone.